Story perspectives

Boston Scientific Q1 Earnings Beat Expectations, Shares Jump 8%

4/23/2026

Summary

Story summary

Boston Scientific Corporation (BSX) reported first-quarter 2026 earnings of $1.34 billion and revenue of $5.20 billion, up 11.6% year over year, in line with expectations.
The company lowered its full-year guidance to adjusted EPS of $3.34 to $3.41 and organic revenue growth of 6.5% to 8%.
Boston Scientific attributed the revision to challenges in its Watchman heart device and electrophysiology business.
Shares rose over 8% after the earnings announcement, signaling investor optimism about future performance.

1 of 1

Story summary

Boston Scientific Corporation (BSX) reported first-quarter 2026 earnings of $1.34 billion and revenue of $5.20 billion, up 11.6% year over year, in line with expectations.
The company lowered its full-year guidance to adjusted EPS of $3.34 to $3.41 and organic revenue growth of 6.5% to 8%.
Boston Scientific attributed the revision to challenges in its Watchman heart device and electrophysiology business.
Shares rose over 8% after the earnings announcement, signaling investor optimism about future performance.